Participated · Seed · Oct 2025

Founded in 2022, Aisthesis Medical develops hospital-grade clinical decision-support tools that leverage multimodal data, digital-twin technology and explainable AI. Its flagship product, VIOSync Sepsis Prediction Index (SPI), securely ingests patient data from hospital systems to forecast the likelihood of sepsis within the next 48 hours and surfaces the key physiological drivers behind the risk score. The company targets a critical clinical need, as sepsis causes more than 11 million deaths annually and often goes undetected until deterioration occurs. Recent funding is being directed toward CE MDR regulatory submission, expanded clinical validation studies across leading UK and EU hospitals, and team growth ahead of NHS and international pilot rollouts. Aisthesis partners with ICU clinicians—including NHS consultant Dr. Savvas Vlachos—to ensure the platform fits real-world workflows. The founding team holds AI doctorates from institutions such as Imperial College London and ETH Zurich and is supported by a network of industry advisors. Although still pre-revenue, the company aims to become the standard for proactive sepsis prevention in hospitals worldwide.

Participated · Seed · Nov 2021

Finloup is a Greek-founded startup offering monthly leasing of electronic devices to customers ranging from sole proprietorships and freelancers to SMEs and large organisations. Founded in 2020 by CEO Antonis Prentzas and CFO Marios Noutsos, the company pivoted from a consumer BNPL model about a year and a half ago to focus on B2B leasing and strengthening clients' ESG indicators. Its service enables companies to free up funds, access up-to-date devices at lower cost, and redirect capital to growth activities. Finloup plans to use the new capital to expand market presence, particularly targeting startups and business customers. Financially, the company secured over €1M in the recent round and previously raised €1M in a 2021 pre-seed for product and business development. Current investors include Velocity Partners, Genesis Ventures, UAE-based Praxia Capital, and a number of business angels. Finloup is a Greek BNPL startup that offers interest-free, commission-based installment payments to consumers while charging merchants a commission on basket size and no upfront fees. Its core product uses a proprietary credit-scoring methodology that leverages open-banking data alongside proprietary and third-party data to predict consumer affordability. Since launching in 2020 the company has partnered with 21 merchants in Greece, including Funky Buddha, and reports a 40% increase in average consumer baskets in the months it has been operating. With the new funding Finloup plans to onboard at least 200 businesses within 12–18 months and expand into neighboring Southeast European markets. The team is prioritizing markets enabled by open banking, covered by existing customers, and supported by local startup investors.